Target intelligence / Profile preview

Copper(II) ion (Cu2+) (Cu2+)

Target
Cu2+
Molecular classification
Metal ion, Inorganic cofactor
01

Overview

Copper(II) ions (Cu2+) within the free or exchangeable copper pool represent the fraction of systemic copper that is not tightly bound to ceruloplasmin, making it chemically reactive and biologically available (Gromadzka et al., 2014). This pool is essential for the function of vital enzymes such as cytochrome c oxidase and superoxide dismutase, yet it must be strictly regulated to prevent oxidative damage via Fenton-like chemistry (StatPearls, 2023). In Wilson disease, mutations in the ATP7B transporter lead to an expansion of this labile pool, causing toxic accumulation in the liver and brain (NIH, 2023). Conversely, in oncology, this pool is targeted by ionophores like elesclomol to trigger cuproptosis, a form of regulated cell death characterized by the aggregation of lipoylated mitochondrial proteins (Tsvetkov et al., 2022). Therapeutic strategies focus on either sequestering excess Cu2+ using chelators like penicillamine to promote excretion or redistributing it to induce selective cytotoxicity in malignant cells (PubChem, 2024).

Other names
Labile copper poolExchangeable copperFree copperNon-ceruloplasmin bound copperCupric ionExchangeable copper pool
02

Mechanism of action

Chelation of excess copper to facilitate urinary excretion; ionophore-mediated intracellular copper delivery to induce cuproptosis; inhibition of intestinal copper absorption via induction of metallothionein.

03

Biological functions

Redox signalingEnzyme cofactorMitochondrial respirationCell death regulation (Cuproptosis)Iron metabolism
04

Disease associations

Wilson diseaseMenkes diseaseCancerAlzheimer's diseaseLiver cirrhosisHepatotoxicity
05

Safety considerations

Iatrogenic copper deficiency (anemia and neutropenia)Neurological worsening upon treatment initiation in Wilson diseaseNephrotoxicityBone marrow suppressionSecondary zinc deficiencyTeratogenicity
06

Interacting drugs

Penicillamine

6 more in the full profile.

07

Biomarkers

Non-ceruloplasmin bound copper (NCC)Exchangeable copper (CuEx)Relative exchangeable copper (REC)24-hour urinary copper excretion

Beyond the preview

Go deeper on Copper(II) ion (Cu2+) (Cu2+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper(II) ion (Cu2+) (Cu2+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call